NovaBay Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • NovaBay Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $41M, a 9.66% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $41M +$3.62M +9.66% Dec 31, 2023 10-K 2024-03-26
Q4 2022 $37.4M +$1.76M +4.94% Dec 31, 2022 10-K 2024-03-26
Q4 2021 $35.7M +$2.78M +8.44% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $32.9M +$1.29M +4.07% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $31.6M +$2.22M +7.54% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $29.4M +$851K +2.98% Dec 31, 2018 10-K 2020-03-26
Q4 2017 $28.5M -$10.1M -26.1% Dec 31, 2017 10-K 2019-03-29
Q4 2016 $38.6M +$3.64M +10.4% Dec 31, 2016 10-K 2018-03-21
Q4 2015 $35M +$8.1M +30.1% Dec 31, 2015 10-K 2017-03-23
Q4 2014 $26.9M +$6.29M +30.5% Dec 31, 2014 10-K 2016-03-04
Q4 2013 $20.6M +$6.1M +42% Dec 31, 2013 10-K 2015-03-26
Q4 2012 $14.5M +$13.1M +905% Dec 31, 2012 10-K 2014-03-06
Q4 2011 $1.45M +$266K +22.6% Dec 31, 2011 10-K 2013-03-14
Q4 2010 $1.18M Dec 31, 2010 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.